Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Jan 27 · below the Ichimoku cloud · RSI 20 (oversold) · MACD below its signal · 4% above its 52-week low
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $663.1K | 0.00% | 277.46K | −4.8% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NAII trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 5, 2026 | Ledoux Mark AChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 20K | — |
| Mar 5, 2026 | Dunn Alan GDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Mar 5, 2026 | Wolf Kenneth EugenePresident | Stock Award(Grant) at price 0.00 per share. | 15K | — |
| Mar 5, 2026 | Ramanathan Guru PDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Mar 5, 2026 | Fortin Michael E.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 12K | — |
| Mar 5, 2026 | Matherly Laura KayDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Mar 5, 2026 | Ledoux Mark AChief Executive Officer | Purchase at price 2.75 - 2.80 per share. | 1.3K | $3.47K |
| Mar 1, 2026 | Ledoux Mark AChief Executive Officer | Purchase at price 2.79 - 2.85 per share. | 1K | $2.82K |
| Feb 26, 2026 | Ledoux Mark AChief Executive Officer | Purchase at price 2.80 - 2.85 per share. | 1.3K | $3.53K |
| Feb 23, 2026 | Ledoux Mark AChief Executive Officer | Purchase at price 2.66 - 2.71 per share. | 2K | $5.40K |
| Feb 18, 2026 | Ledoux Mark AChief Executive Officer | Purchase at price 2.56 - 2.60 per share. | 4.5K | $11.60K |
| Dec 22, 2025 | Ledoux Mark AChief Executive Officer | Stock Gift at price 0.00 per share. | 10K | — |
| Mar 6, 2025 | Dunn Alan GDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Mar 6, 2025 | Ramanathan Guru PDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Mar 6, 2025 | Matherly Laura KayDirector | Stock Award(Grant) at price 0.00 per share. | 8K | — |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.5 | -33.9 | -3.0 | 1.5 | -4.9 | -5.9 | -4.2 | -7.9 | -29.4 | -22.8 | −67.9% | ||
| 2025 | -0.5 | -7.0 | -13.8 | -12.8 | 10.7 | -1.2 | 10.7 | 2.8 | -23.6 | -4.2 | 33.0 | -1.4 | −16.9% |
| 2024 | -4.9 | -2.7 | 0.8 | 2.1 | 3.7 | -6.7 | -4.8 | -5.2 | 5.5 | -20.2 | 2.6 | -8.1 | −34.0% |
| 2023 | 6.1 | 2.2 | 1.3 | -3.4 | -16.3 | -3.5 | 0.0 | -13.9 | 4.7 | -8.0 | -2.5 | 12.2 | −22.2% |
| 2022 | 3.6 | -15.6 | 4.2 | -15.0 | 7.3 | -0.6 | -3.2 | 13.7 | -19.4 | -3.8 | -17.6 | 14.1 | −33.7% |
| 2021 | 35.7 | 9.3 | -2.2 | -2.3 | -8.1 | 22.0 | 5.2 | -11.1 | -14.2 | -6.7 | 2.6 | -2.2 | +19.5% |
| 2020 | 1.4 | -11.0 | -12.5 | 9.5 | -1.0 | 0.1 | -0.4 | 17.5 | -5.6 | 2.5 | 28.8 | 6.2 | +32.7% |
| 2019 | 13.9 | 4.6 | -1.8 | 13.1 | -5.9 | -4.7 | -13.5 | -3.9 | -13.9 | 6.5 | -12.7 | 2.8 | −18.8% |
| 2018 | 8.3 | 5.8 | -6.8 | -8.6 | 9.0 | -7.3 | 0.0 | -5.9 | 2.6 | -4.4 | 7.2 | -2.1 | −4.6% |
| 2017 | 0.9 | -20.2 | -3.3 | 10.8 | 10.8 | -7.9 | 0.5 | 10.0 | -1.8 | -1.9 | -2.8 | 0.0 | −8.8% |
| 2016 | -23.1 | 55.7 | 9.3 | -22.3 | 17.7 | -10.8 | -3.4 | -4.2 | 28.7 | -4.1 | -2.8 | -7.8 | +9.3% |
| 2015 | -0.6 | 3.9 | -0.9 | 2.9 | 2.1 | -1.6 | 6.2 | -2.0 | 6.6 | -6.2 | 30.2 | 34.6 | +93.3% |
| 2014 | -5.6 | 1.1 | 1.9 | 7.6 | 1.4 | -10.8 | 1.5 | -0.2 | 21.1 | -5.6 | -10.5 | -2.4 | −4.1% |
| 2013 | 4.8 | -5.1 | -3.0 | -7.2 | 8.7 | -5.5 | 5.9 | 5.5 | 11.7 | 5.9 | -7.4 | -1.1 | +11.2% |
| 2012 | 3.4 | -30.3 | -1.9 | 6.1 | 13.4 | 1.9 | -12.4 | -8.3 | 0.0 | 2.3 | -8.3 | -13.0 | −43.2% |
| 2011 | -5.2 | 1.7 | 4.3 | -19.2 | -4.4 | 10.8 | -0.2 | 1.9 | -16.9 | 49.9 | 45.6 | -0.5 | +57.9% |
| 2010 | 0.6 | 7.6 | -3.9 | -5.3 | -3.7 | -13.6 | 14.5 | -0.6 | 9.5 | -13.4 | -0.1 | -18.2 | −27.7% |
| 2009 | 0.0 | -1.6 | 3.2 | -1.5 | -0.8 | 11.1 | -3.4 | -0.2 | 20.7 | -3.6 | 3.4 | -0.6 | +27.0% |
| 2008 | -1.5 | 7.2 | -1.2 | -18.6 | 7.1 | 1.8 | -4.0 | 0.3 | -8.3 | -8.5 | -7.0 | 1.7 | −29.3% |
| 2007 | 3.8 | -1.1 | -10.1 | -0.4 | -2.8 | -7.0 | -0.7 | 0.0 | -12.4 | 22.0 | 5.6 | 6.8 | −0.5% |
No analyst coverage for this instrument.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally. The company operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, and regulatory review. In addition, the company sells beta-alanine ingredients under the CarnoSyn, TriBsynm, CarnoSyn 4X, and SR CarnoSyn names. It manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. The company's private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.